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ABSTRACT
Introduction: To evaluate the complications,
efficacy of medical and surgical treatment, and
outcome in patients with necrotizing scleritis
and peripheral ulcerative keratitis associated
with Wegener’s granulomatosis.
Methods: The authors reviewed a series of
seven patients with Wegener’s granulomatosis
treated in the Corneal Department of
Zhongshan Ophthalmic Center and the
Department of Ophthalmology of Kashgar
First People’s Hospital. A detailed chart review
was performed to determine demographic
characteristics, ocular presentation, biopsy and
laboratory testing results, treatment, and final
outcome.
Results: Wegener’s granulomatosis was
indicated by ocular and/or systemic findings;
biopsy and immunohistochemistry results
supported the diagnosis. Patients with
necrotizing scleritis and/or peripheral ulcerative
keratitis received cytotoxic immunosuppressive
therapy; this, in conjunction with surgical
treatment, halted the relentlessly progressive
inflammation and preserved the integrity of the
globe in 78% of eyes. Best-Corrected Visual
Acuity remained stable in four of nine eyes, was
improved in two of nine eyes, and decreased in
three of nine eyes (secondary to cataract and/or
stromal scarring). Although one patient died,
treatment with corticosteroids and cytotoxic
agents dramatically improved outcomes in
these patients.
Conclusion: Necrotizing scleritis and peripheral
ulcerative keratitis often have a poor visual
outcome, and may herald an underlying
systemic vasculitis. Wegener’s granulomatosis,
with the associated necrotizing scleritis and
peripheral ulcerative keratitis, should be
managed with aggressive immunosuppression
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to avoid the associated morbidity and mortality.
Thus, the ophthalmologist may play a significant
role in its early diagnosis and treatment.
Keywords: Antineutrophil cytoplasmic
antibodies; Biopsy; Granulomatous lesions;
Immunosuppressive agents; Necrotizing
scleritis; Peripheral ulcerative keratitis;
Wegener’s granulomatosis
INTRODUCTION
Wegener’s granulomatosis (WG) is
characterized by necrotizing granulomatous
lesions of the upper and lower
respiratory tract, together with a necrotizing
glomerulonephritis and widespread
disseminated vasculitis. The form of WG is
designated ‘‘limited’’ when only one or two
organ systems are involved without renal
involvement [1]. Cases have been reported of
patients having limited forms of WG with
involvement of the respiratory tract, skin,
palatal, ear, and salivary gland [2, 3]. Ahmed
et al. [4] reported cases of very limited WG,
having only ocular involvement and no
respiratory or renal disease. Untreated WG is
rapidly fatal, with renal failure being the
primary cause of death. In the localized form
of WG, the absence of renal involvement
reduces the mortality rate [2]. Onset of renal
disease is associated with a mean survival of
5 months; 82% of patients die within 1 year,
and more than 90% die in 2 years [5]. Harper
et al. [6] reported patients with limited WG
who progressively evolved to systemic WG over
the course of follow-up. This concept of
progressively evolving WG with increased
organ involvement is important, since timely
therapeutic intervention can prevent the
otherwise probable morbidity and mortality.
The diagnosis of limited forms of WG can be
difficult. Early identification of the limited
ophthalmic variant has been based on a
combination of histopathologic findings and
positive immunolabeling with cytoplasmic
antineutrophil cytoplasmic antibodies
(cANCA).
The therapeutic outcome of ophthalmic
complications of WG in the USA and Europe
has significantly improved over recent years
[7], largely as a result of earlier diagnosis
and treatment with a combination of
glucocorticoids and cyclophosphamide (CP);
however, there is a dearth of publications
concerning the natural history, diagnosis and
treatment of WG in Asian populations [8]. To
rectify this deficiency, the authors review the
clinical features, management, and visual
outcomes of seven cases with necrotizing
scleritis (NS) and/or peripheral ulcerative
keratitis (PUK) associated with WG in a
Chinese population.
METHODS AND PATIENTS
A review of the records of patients with scleritis
seen in the Corneal Department of Zhongshan
Ophthalmic Center between 2005 and 2012, and
the Department of Ophthalmology of Kashgar
First People’s Hospital between 2009 and 2012
was performed. The Ethics Committees of
Zhongshan Ophthalmic Center and Kashgar
First People’s Hospital approved this
retrospective study, which has been conducted
according to the principles expressed in the
Helsinki Declaration of 1975, as revised in 2000
and 2008. The Ethics Committees specifically
waived the need for consent.
A comprehensive review of patients
documents was performed. Best-corrected
visual acuity (BCVA) was measured by means of
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a Snellen chart. A detailed ophthalmic
examination, including testing of corneal
touch-sensitivity, slit-lamp examination, ocular
pressure, and fundus examination, was
performed and the site and extent of
pathological changes in the sclera and
associated corneal regions were determined.
The laboratory evaluation included complete
blood count, erythrocyte sedimentation rate
(ESR), rheumatoid factor (RF), antinuclear
antibodies, complement fixation, circulating
immune complexes, cANCA, C-reactive protein
(CRP), renal function studies, urinalysis, sinus
and chest radiographs, Venereal Disease
Research Laboratory (VDRL) testing, and TB
skin testing that was judged to be positive if the
extent of induration was C10 mm. Conjunctival,
corneal, and/or scleral biopsy samples were
collected at the time of ocular surgery to search
for any evidence of granulomatosis or vasculitis,
and scrapings and cultures were analyzed by
Gram- and Giemsa-staining.
Local ocular therapy consisted of topical
dexamethasone and antibiotics (tobramycin
and dexamethasone), topical cyclosporine
(cyclosporin A), mydriatics, and artificial
tears. Corticosteroids (dexamethasone and
prednisone) and immunomodulatory/
cytotoxic drugs [methotrexate (MTX) and CP]
were administered systemically, orally, or
intravenously. The drug dosage was modified
to obtain a good therapeutic effect with
minimal complications of cytotoxic agents,
such as declining leukocyte count.
RESULTS
A review of the records of 145 patients with
scleritis seen in the Corneal Department of
Zhongshan Ophthalmic Center between 2005
and 2012, turned up six cases identified with
positive WG tests. One additional patient with
similar findings was identified among 32
patients with scleritis in the Department of
Ophthalmology of Kashgar First People’s
Hospital between 2009 and 2012. Of the 177
patients with scleritis, diffuse anterior (112
cases) was the most common type of scleritis
observed in this study population, followed by
nodular (31 cases), necrotizing (26 cases), and
posterior scleritis (8 cases). Demographic data
for the seven patients are summarized in
Table 1. There were five men and two
women, with an average age of 52 years
(range 30–65 years). Five patients had
unilateral sign of NS or PUK and two had
bilateral sign of NS or PUK. Five patients had
the limited form of WG, while two had the
complete form. Redness and aching pain in
the eyes were the common presenting
complaints. At presentation, five cases had
corneal involvement (sclerokeratitis), and two
had NS. During 10 months of treatment, one
developed glaucoma, one had choroidal
detachment, and one had secondary cataract.
BCVA was initially less than 20/40 in five cases
(Table 2). Ocular lesions were the initial
manifestations of WG in five of the seven
cases. The duration of ocular signs before the
diagnosis of WG ranged from 25 days for one
patient with unilateral NS and PUK to
4 months for one patient with a unilateral
peripheral corneal ulcer. These two eyes had
been treated surgically before referral to the
authors’ hospital; the unilateral NS plus PUK
was treated with a full-thickness corneal graft
within 4 months, and the other with amniotic
membrane transplantation within 3 months of
the onset of disease symptoms.
Laboratory investigations revealed elevated
ESR and positive cANCA in all seven patients.
Rheumatoid factor was positive in case 3. Chest
X-rays revealed pulmonary cavities and
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1 54/M OD NS Oral, IV CP, MTX
oral
? SPG Glaucoma
OS NS ? SPG Graft melting that was
managed by CP,
glaucoma
2 52/F OS NS, PUK Oral, IV CP oral ? LK Choroidal detachment





4 65/M OS NS Oral, IV MTX oral ? SPG Cataract progression
5 54/M OD PUK Oral, IV CP oral ? LK
6 50/F OD NS, PUK Oral, IV CP oral ?
7 30/M OD NS, PUK Oral CP, IV ? BCL Death on the 102nd day
of admissionOS NS, PUK
BCL bandage contact lens, CP cyclophosphamide, F female, IV intravenous, LK lamellar keratoplasty, M male, MTX
methotrexate, NK necrotizing scleritis, OD right eye, OS left eye, PUK peripheral ulcerative keratitis, SPG scleral patch graft
? Topical cyclosporine treatment
Table 2 Clinical data
Case Eye Diagnosis Serology (1) Initial BCVA Final BCVA Follow-up, months Relapse
1 OD NS cANCA 20/100 20/200 35 Lung granuloma
OS NS cANCA 20/50 20/50 35
2 OS NS, PUK cANCA 20/200 20/200 15
3 OD NS, PUK RF, cANCA 20/100 20/200 21
4 OS NS cANCA 20/40 20/200 14
5 OD PUK cANCA 20/80 20/40 26 NS
6 OD NS, PUK cANCA 20/40 20/30 10
7 OD NS, PUK cANCA 20/100 20/100 4
OS NS, PUK cANCA 20/100 20/100 4
BCVA best-corrected visual acuity, OD right eye, OS left eye, NS necrotizing scleritis, PUK peripheral ulcerative keratitis,
RF rheumatoid factor, cANCA cytoplasmic antineutrophil cytoplasmic antibody
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infiltrates in two patients (cases 6 and 7). X-rays
in cases 1, 2, and 7 revealed mucosal thickening
in the sinuses. Hematuria was seen in two
patients (cases 1 and 7). Histological
examination of nasal biopsies in cases 1 and 2
showed necrotizing giant cell granulomas with
foci of inflammation. Subglottic stenosis of the
pharynx was present in case 2.
Surgery was required in five patients; two
cases of NS received autologous sclera grafts,
two cases of PUK were treated with lamellar
keratoplasty, and one case of paracentral
corneal perforation was repaired with a
tectonic intralamellar patch plus an onlay graft.
In the patients with NS and/or PUK
progressive inflammation was halted by the
combination of immunosuppressive and
surgical therapy in 78% of eyes. BCVA
remained stable in four of nine eyes, was
improved in two of nine eyes, and decreased




A 54-year-old male patient had a 3-month
history of NS with [120 extension in both
eyes. The patient had been given topical
steroids without effect before referral. At
presentation, in addition to mild anterior
uveitis and partial posterior iris synechiae, a
perforation of the sclera was seen at the 3 and 9
o’clock meridians in the right eye, with
disruption of the adjacent limbal arcade; and
scleritis involved the lower half-circumference
in the left eye, with high activity from 7 to 9
o’clock (Fig. 1a). BCVA was 20/100 in the right
eye, and 20/50 in the left. Ocular pressure and
fundus examination were normal in both eyes.
Blood examinations disclosed elevations of
serum CRP and ESR, and positive cANCA. The
results of syphilis serology and tuberculin (TB)
tests were negative. Urinalysis showed
microscopic hematuria and proteinuria, but
creatinine clearance was normal. The chest
X-ray was normal, but skull X-rays revealed
mucosal thickening of the left maxillary sinus.
Histopathology of nasal biopsy tissue revealed
that the mucosa was infiltrated by lymphocytes,
plasma cells, multinucleated giant cells, and
epithelioid histiocytes.
The condition was diagnosed as WG, and
treatment with systemic corticosteroids and
MTX commenced. On October 13, 2005, a
donor sclera graft was customized to the
appropriate size and thickness, secured to the
edges of the resection site of the left eye, and
covered with a conjunctival flap. Histological
analysis of the margin of the necrotic sclera
showed necrotic collagen, inflammatory cells
around the capillary walls, and granulomatous
inflammation with lymphocytes, eosinophils,
epithelioid cells, and multinucleated giant cells
(Fig. 1b). Two weeks later, the conjunctival flap
became retracted, leaving the scleral graft bare;
the scleral graft developed lysis at 9 o’clock
(Fig. 1c), and there were 1? aqueous cells,
posterior iris synechiae, and elevated
intraocular pressure in both eyes. Therefore,
following consultation with a rheumatologist,
the medical treatment was changed to
corticosteroids and CP. The original scleral
graft was re-sutured, and an amniotic
membrane graft was applied; this arrested the
lysis of the scleral graft, which was found to be
vascularized 10 days later (Fig. 1d). The
transplantation of the scleral graft in the right
eye was uneventful (Fig. 1e, f). In both eyes,
direct communication between the anterior and
posterior chambers was established by Yttrium
Aluminium Garnet (YAG) iridotomy to prevent
the blockage of aqueous drainage by the
progressive development of iris synechiae.
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Case 3
A 56-year-old male patient with hyperlipidemia
was referred for treatment of corneal melt. The
patient complained of a recent episode of
redness and photophobia in the right eye.
Ocular history included corneal perforation in
the left eye treated by penetrating keratoplasty
at another hospital 9 months earlier.
Fig. 1 Montage of clinical and histopathology illustrations
(case 1). a Necrotizing scleritis in left eye of a 54-year-old
man with Wegener’s granulomatosis. b Scleral biopsy
specimen from left eye illustrating collagen necrosis, and
granulomatous inﬂammation with lymphocytes, eosino-
phils, epithelioid cells, and multinucleated giant cells
(magniﬁcation 9400; hematoxylin–eosin stain). c The
conjunctival ﬂap has developed retraction, leaving the
scleral graft bare and revealing lysis of the graft in the left
eye. d The lysis of the scleral graft was arrested and the
vascularization of the graft was detected after amniotic
membrane graft transplantation and systemic administra-
tion of cyclophosphamide. e Severe necrotizing disease in
the same patient, with scleral thinning and perforation of
the right eye. f Scleral graft performed after medical control
of disease activity
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On examination, BCVA was 20/100 in the
right eye and no light perception (NLP) in the
left eye. Slit-lamp examination of the left eye
showed phthisis bulbi, while that of the
right eye showed multifocal marginal
infiltrates in the superior cornea, corneal
guttering, and paracentral corneal perforation
in the inferonasal cornea, with normal anterior
chamber depth (Fig. 2a). The fundus appearance
and intraocular pressures in the right eye were
within normal limits.
Laboratory investigations showed an
elevated ESR (134 mm/h) and CRP (168 mg/dL).
The positive cANCA and rheumatoid factor tests
were suggestive of WG. Histopathological
examination of the biopsied nasal mucosa
showed nonspecific inflammatory changes,
and the chest X-ray and renal function
measurements revealed no abnormalities.
The patient was treated with intravenous
methylprednisolone and CP, which led to
amelioration of the ocular inflammation and
corneal melt. A tectonic patch graft was
performed in this case, as follows: a 12-mm
diameter lamellar dissection, using a crescent
blade, was created extending to 1.0 mm from
the perforation edge; then a posterior
intralamellar corneal patch graft, 2 mm larger
than the perforation, was inserted and secured
with buried 10-0 nylon sutures. Finally, an
anterior lamellar donor cornea was dissected
about 2 mm onto the sclera, transferred onto
the recipient bed, and sutured with 10-0 nylon
sutures. Light microscopic examination of the
diseased cornea revealed collagen necrosis, as
well as infiltration of lymphocytes, eosinophils,
epithelioid cells, and multinucleated giant cells
(Fig. 2b). Cultures for bacteria and fungi were
negative, as were stains for acid-fast bacteria.
Oral CP was continued for 8 months. At the
21-month follow-up, vision was 20/200 in the
right eye, and the patient’s ocular condition
remained stable thereafter (Fig. 2c).
Case 6
A 50-year-old female patient had suffered from
redness and pain in the right eye without fever
for 5 weeks. Detailed history revealed decreased
appetite and moderate weight loss over the
previous 3 months. BCVA upon admission was
20/40 in the right eye and 20/30 in the
left eye. Slit-lamp examination demonstrated
granulomatous necrotizing sclerokeratitis,
which involved both cornea and sclera, in the
right eye. The conjunctiva was markedly
hyperemic, the superior sclera was swollen and
inflamed with surface irregularities, and the
superior cornea was inflamed across the limbus
Fig. 2 Patient with necrotizing scleritis and ulcerative
peripheral keratitis (case 3). a Circumferential corneal
inﬁltrates, melting, and paracentral corneal perforation of
the right eye. b Corneal biopsy specimen. Note: necrosis of
corneal stromal collagen and granulomatous inﬂammation,
with lymphocytes, eosinophils, epithelioid cells, and mul-
tinucleated giant cells (magniﬁcation 9200; hematoxylin–
eosin stain). c Lamellar corneoscleral graft with intralamel-
lar patch, which was performed to maintain structural
integrity
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and showed peripheral corneal ulceration with
gutter appearance (Fig. 3a). The anterior
chamber was clear, and the fundus appearance
and intraocular pressure were normal. Clinical
examination of the left eye revealed no
abnormalities. Blood studies showed a normal
white cell count and an elevated ESR (74 mm/h)
and CRP (137 mg/dL). The results of renal
function tests were normal. Sinus films were
normal, but a chest X-ray showed infiltration in
the left lobe, and a nodule and cavitating lesion
in the right lobe of the lung (Fig. 3b). A TB skin
test was negative, but the cANCA test was
positive, raising suspicion of WG. Biopsy of
the sclera showed degradation of collagen,
inflammatory cells around the capillary and
postcapillary venule walls, and infiltrating cells,
including lymphocytes, eosinophils, plasma
cells, epithelioid cells, and multinucleated
giant cells within them (Fig. 3c). The patient
was treated with pulse therapy of intravenous
methylprednisolone and oral CP, with
subsequent subsidence of ocular inflammation
and PUK in the right eye (Fig. 3d). Maintenance
treatment with oral MTX and reducing oral
steroids was continued.
Case 7
A 30-year-old male patient presented with a
3-month history of redness and soreness in both
eyes. The condition was diagnosed as scleritis,
but it failed to respond to topical treatment, and
the patient was referred to the Department of
Ophthalmology in Kashgar’s First Hospital for
ophthalmic investigation. The patient’s medical
history included otitis media complicated with
Fig. 3 Montage of clinical and histopathology illustrations
(case 6). a Necrotizing scleritis and peripheral ulcerative
keratitis. b Chest X-ray showing inﬁltration in the left lung
and a nodule and cavitating lesion in the right lung.
c Scleral biopsy, demonstrating giant cells surrounded by
epithelioid cells, lymphocytes, eosinophils, and plasma cells
(magniﬁcation 9400; hematoxylin–eosin stain). d Control
of the severe necrotizing disease after systemic administra-
tion of corticosteroids and cyclophosphamide
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bacterial pneumonia 9 months previously. Six
months later, the patient presented with renal
failure and arterial hypertension.
Ocular examination disclosed BCVA of
20/100 in both eyes. Slit-lamp examination
demonstrated NS and PUK in the right eye
(Fig. 4a), and necrotizing anterior scleritis,
associated with inferior peripheral corneal
gutter and invasion by new vessels from the
limbus, in the left eye (Fig. 4b). The anterior
chamber was deep, with 1? cells in the right eye
and no cells in the left eye. The diagnosis of
bilateral NS and PUK was made, and because of
the clinical and systemic findings, WG was
considered.
X-rays revealed mucosal thickening of the
right maxillary sinus, and cavitation within
areas of pulmonary consolidation. Laboratory
tests revealed normocytic normochromic
anemia (hemoglobin 7.4 g/dL), and elevated
CRP (43 mg/dL) and ESR (56 mm/h). The
leukocyte count was slightly elevated
(11,200 cells/mm3), serum creatinine was
4.5 mg/dL, and cANCA titer was positive.
Urinalysis was positive for protein, and
urinary sediment analysis revealed 6
erythrocytes per high-power field.
The patient was treated with 1,000 mg
intravenous CP (every 3 weeks), together with
oral prednisone (1 mg/kg/day), but continued
having eye problems. Four weeks after the drug
regimen was begun, limbal perforation occurred
at the 7 o’clock in the left eye (Fig. 4c);
subsequently, more than 9 weeks after
limbal perforation, the patient’s respiratory
function had deteriorated, and serial plain
chest radiographs revealed rapidly worsening
airspace opacities. The patient was transferred
to the intensive care unit and eventually died of
respiratory failure.
DISCUSSION
Wegener’s granulomatosis is an insidious
disease that affects patients of any age. It
consists of a triad: necrotizing granulomatous
vasculitis of the upper and the lower respiratory
tract, variable degrees of small-vessel vasculitis,
and focal necrotizing glomerulonephritis.
Classic WG is considered to be a systemic
disease; however, a localized form of WG,
limited to the upper and lower respiratory
tracts, has been reported [9]. Ocular signs and
symptoms can be a major component of either
classic or limited WG. Ocular manifestations
include orbital involvement with proptosis,
scleritis, corneal ulceration, uveitis, and
nasolacrimal duct obstruction [10].
Fig. 4 Clinical pictures of a 30-year-old man with classic
Wegener’s granulomatosis (case 7). a Slit-lamp examination
of the right eye, showing necrotizing scleritis, multiple
perilimbal inﬁltrates, and engorged scleral vessels.
b Necrotizing scleritis and peripheral ulcerative keratitis
of the left eye. c Limbal perforation, which developed in the
left eye despite systemic immunosuppression
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Scleritis has been reported to occur in
16–38% of patients with WG [11]. NS is
strongly associated with systemic disease, and
is seen in more than half of the patients with
ocular WG [6]. A mortality rate as high as 54%
has been reported in patients with NS who are
not undergoing immunosuppressive therapy
[12]. NS was found in 86% of the present
patients, and corneal disease was present in
most. PUK is typically associated with an
underlying systemic disease, most commonly
rheumatoid arthritis followed by WG [13]. PUK
and scleritis, being associated with rheumatoid
arthritis, are manifestations of vasculitis.
Scleritis with inflammation, as seen in classic
rheumatoid arthritis, does not produce the
heaped-up granulomatous lesions seen in
systemic vasculitis or Wegener’s disease. The
episcleral lesion in patients with rheumatoid
arthritis is very thin and, therefore, unlikely to
become heavily infiltrated and reactive.
It is also probable that the types of
inflammatory response in these two diseases
are fundamentally different, for a number of
reasons. First, the predominant feature in the
NS of rheumatoid arthritis is characterized by
vascular occlusion, whereas that seen in the
vasculitis of WG is characterized by new vessel
formation. Second, the corneal changes in
rheumatoid arthritis remain confined to the
limbus, whereas the inflammatory changes in
WG involve the limbal area and progress from
sclera to cornea. Third, corneal melt in
rheumatoid arthritis usually occurs in patients
with long-standing disease; for example, one
study found a mean of 19.6 years between the
diagnosis of rheumatoid arthritis and the onset
of PUK [14], but in WG, corneal melt can occur
earlier. Regardless of the underlying condition
with which it is associated; however, corneal
melt can occur swiftly once inflammation
begins within the cornea, and visual loss can
ensue within days. Other disease entities also
may resemble PUK. Mooren’s ulcer has a similar
appearance, but no systemic or local
associations exist. Terrien’s marginal
degeneration also presents with peripheral
corneal thinning; however, this condition is
noninflammatory and in Terrien’s, unlike PUK,
the epithelium remains intact.
Biopsy and histopathological examination
of affected tissues are important for
confirming the diagnosis of WG and ruling
out other diseases [7]. In the present cases,
biopsies of the necrotic sclera revealed a richly
polymorphous inflammatory infiltrate,
typically featuring plasma cells,
lymphocytes, eosinophils, dispersed or
clustered epithelioid histiocytes, and
multinucleated giant cells. Extravascular
granulomas were present in six of the seven
cases, and inflammatory microangiopathy was
observed in five cases. McCluskey et al. [15]
observed that independent areas of
necrotizing granulomatous lesions account
for much of the tissue destruction, and
purely granulomatous disease has been
proposed as an early and sometimes the only
manifestation of WG [16].
Since WG seldom manifests the classic triad
of vasculitis, necrosis, and granulomatous
inflammation, the diagnosis must be based on
a range of clinical and pathological findings.
The cANCA test is specific and sensitive in the
diagnosis of WG. All cases in the present series
had positive cANCA titers, as measured by
enzyme-linked immunosorbent assay,
consistent with its validity for this purpose.
Unfortunately, the relative rarity of scleritis in
general, and of WG-associated scleritis in
particular, precludes the examination of a
large series of patients. The results of this
study demonstrate that cANCA is highly
sensitive and specific even for limited WG
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when scleritis is the initial clinical presentation
of disease. Because delay in diagnosis and
initiation of appropriate treatment in WG can
result in vision loss, organ damage, and even
death, some have argued for including a
positive cANCA titre as a fifth criterion
[17]—with nasal or oral inflammation,
abnormal chest radiograph, active urine
sediment, and positive biopsy—in the
modified American College of Rheumatology
criteria for the diagnosis of WG.
Because scleritis may be secondary to a
systemic disease (as in the cases in this study),
and because the inflammatory cells responsible
for it originate far from the eye, treatment with
systemic corticosteroids and cytotoxic agents is
often effective. The condition in the first
patient in the present study did not respond
to topical dexamethasone for scleritis, but did
improve upon treatment with systemic
corticosteroids and MTX. Lysis was evident
within the scleral graft, despite treatment with
systemic corticosteroids and MTX, and finally
resolved only when CP was added. CP is
considered the preferred drug for WG because
of its proven efficacy [7], and is associated with
fewer disease relapses (although more side
effects). There is a strong requirement for a
potent but low toxicity treatment on which a
patient can possibly be maintained for several
years. MTX may be used to maintain remission
[18].
Scleral and corneal thinning, which can lead
to staphyloma formation, scleral or corneal
perforation, and uveal exposure, is not an
unusual complication of scleritis and
keratoscleritis in WG. Surgical reinforcement
of the thinned or perforated sclera or cornea is
necessary to prevent prolapse of ocular contents
and secondary infection. Various types of
allografts have been used to maintain
structural integrity in such cases [19–21].
Scleral grafts have many advantages in this
situation, as they are readily available from
donor eyes, easy to handle, and naturally
curved to match the host sclera; they are also
avascular and well tolerated, causing little or no
inflammatory reaction. Case 1 developed graft
lysis within 1 month; this was managed with
extensive medical therapy, plus covering by an
amniotic membrane graft, which preserved the
structural integrity of the eye by facilitating
re-epithelialization and vascularization. It is
important for surgery to be deferred until
medical therapy has controlled the primary
disease [22], and for the scleral graft to be
covered with a conjunctival flap to prevent its
lysis. If the adjacent conjunctiva cannot be
mobilized, an amniotic membrane graft may
be considered. The amniotic membrane is
endowed with anti-inflammatory and
epithelialization-promoting properties, it is
also immunologically inert and is widely used
for ocular surface reconstruction. Amniotic
membrane transplantation is only an adjunct
to scleral patch grafting, as it reduces
inflammation and promotes epithelialization,
but it may not provide sufficient structural
rigidity.
Surgical resection of conjunctival tissue
adjacent to foci of sclerokeratitis has been
promoted as a means of decreasing access of
inflammatory cells and factors to the peripheral
cornea. A retrospective study of 38 patients with
sclerokeratitis who underwent adjacent
conjunctival biopsy [23] found vasculitis in 20
biopsies. Eighteen of the 20 biopsy-positive
patients were treated with chemotherapy; 17
of the 18 had no progression of ulceration. In
the two patients not treated with
chemotherapy, surgical management stabilized
the disease. However, this treatment is
controversial, as it is not uniformly agreed
that resection alters the course of disease.
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CONCLUSION
Because of the diversity of the ocular
manifestations and the rarity of the disease,
WG presents a difficult clinical diagnostic
problem. A combination of suggestive biopsy
results and elevated cANCA titer is helpful for
early diagnosis in cases of limited ophthalmic
WG. Immunosuppressive therapy should be
instituted after confirming the diagnosis, to
prevent progression of the systemic disease.
Specific surgical options may be considered in
some cases to preserve the integrity of the ocular
globe. In order to avoid the associated morbidity
and mortality, WG, with the associated NS and
PUK, should be managed with aggressive
immunosuppression. The ophthalmologist
may have an essential role in the early
diagnosis and treatment of this disease.
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